EUVIMEDEUVIMED entdecken
Crossref

The microglial innate immune receptors TREM-1 and TREM-2 in the anterior cingulate cortex (ACC) drive visceral hypersensitivity and depressive-like behaviors following DSS-induced colitis

Ke Wu, Yue-Ying Liu, Shuai Shao, Wei Song, Xing-Han Chen, Yu-Ting Dong, Yong-Mei Zhang

Brain, Behavior, and Immunity · 2023-08 · 112 · 96-117

DOI: 10.1016/j.bbi.2023.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2023-08. Verfasst von Ke Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou, China; Jiangsu Province Key Laboratory of Anesthesiology,…. Hauptthemen laut MEDLINE: Colitis, Immunity, Innate, Triggering Receptor Expressed on Myeloid Cells-1, Receptors, Immunologic. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 120 Literaturangaben. Gefördert von: Qinglan Project of Jiangsu Province of China, Xuzhou Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic condition with a high recurrence rate. To date, the clinical treatment of IBD mainly focuses on inflammation and gastrointestinal symptoms while ignoring the accompanying visceral pain, anxiety, depression, and other emotional symptoms. Evidence is accumulating that bi-directional communication between the gut and the brain is indispensable in the pathophysiology of IBD and its comorbidities. Increasing efforts have been focused on elucidating the central immune mechanisms in visceral hypersensitivity and depression following colitis. The triggering receptors expressed on myeloid cells-1/2 (TREM-1/2) are newly identified receptors that can be expressed on microglia. In particular, TREM-1 acts as an immune and inflammatory response amplifier, while TREM-2 may function as a molecule with a putative antagonist role to TREM-1. In the present study, using the dextran sulfate sodium (DSS)-induced colitis model, we found that peripheral inflammation induced microglial and glutamatergic neuronal activation in the anterior cingulate cortex (ACC). Microglial ablation mitigated visceral hypersensitivity in the inflammation phase rather than in the remission phase, subsequently preventing the emergence of depressive-like behaviors in the remission phase. Moreover, a further mechanistic study revealed that overexpression of TREM-1 and TREM-2 remarkably aggravated DSS-induced neuropathology. The improved outcome was achieved by modifying the balance of TREM-1 and TREM-2 via genetic and pharmacological means. Specifically, a deficiency of TREM-1 attenuated visceral hyperpathia in the inflammatory phase, and a TREM-2 deficiency improved depression-like symptoms in the remission phase. Taken together, our findings provide insights into mechanism-based therapy for inflammatory disorders and establish that microglial innate immune receptors TREM-1 and TREM-2 may represent a therapeutic target for the treatment of pain and psychological comorbidities associated with chronic inflammatory diseases by modulating neuroinflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisImmunity, InnateTriggering Receptor Expressed on Myeloid Cells-1Receptors, ImmunologicHumansGyrus CinguliInflammationMicrogliaAnimalsMiceMembrane Glycoproteins

Stichwörter der Autor:innen

Anterior cingulate cortexDepressionInflammatory bowel diseaseMicrogliaTREM-1TREM-2Visceral hypersensitivity

Substanzen

Triggering Receptor Expressed on Myeloid Cells-1Receptors, ImmunologicTREM1 protein, mouseTrem2 protein, mouseMembrane Glycoproteins

Autor:innen und Institutionen

  • NMPA Key Laboratory for Research and Evaluation of Narcotic and Psychotropic Drugs, Xuzhou, China; Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, China; Jiangsu Province Key Labora…

Förderung

  • Qinglan Project of Jiangsu Province of China
  • Xuzhou Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Wu, K., Liu, Y. Y., Shao, S., Song, W., Chen, X. H., Dong, Y. T., & Zhang, Y. M. (2023). The microglial innate immune receptors TREM-1 and TREM-2 in the anterior cingulate cortex (ACC) drive visceral hypersensitivity and depressive-like behaviors following DSS-induced colitis. Brain, Behavior, and Immunity, 112, 96-117. https://doi.org/10.1016/j.bbi.2023.06.003

Vancouver

Wu K, Liu YY, Shao S, Song W, Chen XH, Dong YT, et al. The microglial innate immune receptors TREM-1 and TREM-2 in the anterior cingulate cortex (ACC) drive visceral hypersensitivity and depressive-like behaviors following DSS-induced colitis. Brain, Behavior, and Immunity. 2023;112:96-117. doi:10.1016/j.bbi.2023.06.003

BibTeX
@article{Wu2023,
  author = {Wu, Ke and Liu, Yue-Ying and Shao, Shuai and Song, Wei and Chen, Xing-Han and Dong, Yu-Ting and Zhang, Yong-Mei},
  title = {The microglial innate immune receptors TREM-1 and TREM-2 in the anterior cingulate cortex (ACC) drive visceral hypersensitivity and depressive-like behaviors following DSS-induced colitis},
  journal = {Brain, Behavior, and Immunity},
  year = {2023},
  volume = {112},
  pages = {96--117},
  doi = {10.1016/j.bbi.2023.06.003}
}
Kostenlos starten →